Mandolesi M, Sheward D, Hanke L, Ma J, Pushparaj P, Perez Vidakovics L
Cell Rep Med. 2021; 2(4):100252.
PMID: 33842900
PMC: 8020888.
DOI: 10.1016/j.xcrm.2021.100252.
Basu M, Piepenbrink M, Francois C, Roche F, Zheng B, Spencer D
Cell Rep Med. 2020; 1(2).
PMID: 32577626
PMC: 7311075.
DOI: 10.1016/j.xcrm.2020.100015.
Klasse P, Ozorowski G, Sanders R, Moore J
Cell Host Microbe. 2020; 27(4):507-518.
PMID: 32272076
PMC: 7187920.
DOI: 10.1016/j.chom.2020.03.018.
Pauthner M, Nkolola J, Havenar-Daughton C, Murrell B, Reiss S, Bastidas R
Immunity. 2018; 50(1):241-252.e6.
PMID: 30552025
PMC: 6335502.
DOI: 10.1016/j.immuni.2018.11.011.
Lindgren G, Ols S, Liang F, Thompson E, Lin A, Hellgren F
Front Immunol. 2017; 8:1539.
PMID: 29181005
PMC: 5693886.
DOI: 10.3389/fimmu.2017.01539.
Development of targeted adjuvants for HIV-1 vaccines.
Liu J, Ostrowski M
AIDS Res Ther. 2017; 14(1):43.
PMID: 28893282
PMC: 5594534.
DOI: 10.1186/s12981-017-0165-8.
What Are the Most Powerful Immunogen Design Vaccine Strategies? Reverse Vaccinology 2.0 Shows Great Promise.
Burton D
Cold Spring Harb Perspect Biol. 2017; 9(11).
PMID: 28159875
PMC: 5540812.
DOI: 10.1101/cshperspect.a030262.
Evolution of B cell analysis and Env trimer redesign.
Karlsson Hedestam G, Guenaga J, Corcoran M, Wyatt R
Immunol Rev. 2017; 275(1):183-202.
PMID: 28133805
PMC: 5301504.
DOI: 10.1111/imr.12515.
Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.
Heydarchi B, Center R, Bebbington J, Cuthbertson J, Gonelli C, Khoury G
MAbs. 2016; 9(3):550-566.
PMID: 27996375
PMC: 5384801.
DOI: 10.1080/19420862.2016.1270491.
Repertoire comparison of the B-cell receptor-encoding loci in humans and rhesus macaques by next-generation sequencing.
Vigdorovich V, Oliver B, Carbonetti S, Dambrauskas N, Lange M, Yacoob C
Clin Transl Immunology. 2016; 5(7):e93.
PMID: 27525066
PMC: 4973324.
DOI: 10.1038/cti.2016.42.
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.
OConnell R, Excler J, Polonis V, Ratto-Kim S, Cox J, Jagodzinski L
J Infect Dis. 2016; 213(12):1946-54.
PMID: 26908741
PMC: 4878724.
DOI: 10.1093/infdis/jiw059.
Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization.
Phad G, Vazquez Bernat N, Feng Y, Ingale J, Martinez Murillo P, ODell S
J Immunol. 2015; 194(12):5903-14.
PMID: 25964491
PMC: 4458414.
DOI: 10.4049/jimmunol.1500122.
Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation.
Martinez P, Sundling C, ODell S, Mascola J, Wyatt R, Karlsson Hedestam G
Sci Rep. 2015; 5:8925.
PMID: 25762407
PMC: 4356977.
DOI: 10.1038/srep08925.
An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
Yu H, Tian D, Wang J, Guo C, Li Y, Wang X
PLoS One. 2014; 9(12):e115047.
PMID: 25546013
PMC: 4278894.
DOI: 10.1371/journal.pone.0115047.
Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development.
Lewis G, DeVico A, Gallo R
Proc Natl Acad Sci U S A. 2014; 111(44):15614-21.
PMID: 25349379
PMC: 4226080.
DOI: 10.1073/pnas.1413550111.
HIV-1 Env-specific memory and germinal center B cells in C57BL/6 mice.
Soldemo M, Pedersen G, Karlsson Hedestam G
Viruses. 2014; 6(9):3400-14.
PMID: 25198199
PMC: 4189027.
DOI: 10.3390/v6093400.
Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.
Excler J, Ake J, Robb M, Kim J, Plotkin S
Clin Vaccine Immunol. 2014; 21(8):1023-36.
PMID: 24920599
PMC: 4135913.
DOI: 10.1128/CVI.00230-14.
HIV-1 vaccines: challenges and new perspectives.
Excler J, Robb M, Kim J
Hum Vaccin Immunother. 2014; 10(6):1734-46.
PMID: 24637946
PMC: 5396234.
DOI: 10.4161/hv.28462.
Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.
Vargas-Inchaustegui D, Robert-Guroff M
Curr HIV Res. 2013; 11(5):407-20.
PMID: 24191937
PMC: 6288814.
DOI: 10.2174/1570162x113116660063.
Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates.
Chakrabarti B, Feng Y, Sharma S, McKee K, Karlsson Hedestam G, LaBranche C
J Virol. 2013; 87(24):13239-51.
PMID: 24067980
PMC: 3838230.
DOI: 10.1128/JVI.01247-13.